Dark

CTXR
Citius Pharmaceuticals Inc. Common
stock NASDAQ

At Close

Aug 5, 2026 3:59:58 PM EDT

0.7700USD+22.222%(+0.1400)5,049,744

0.6600Bid 0.8900Ask 0.2300Spread

Pre-market

Aug 5, 2026 9:28:30 AM EDT

0.6400USD+1.587%(+0.0100)30,408

After-hours

Aug 5, 2026 4:59:30 PM EDT

0.7435USD-3.442%(-0.0265)62,355

OverviewOptionsHistoricalExchangesShortsNews

Jan 18, 2022

10:02AM EST HC Wainwright & Co. Maintains Buy on Citius Pharmaceuticals, Raises Price Target to $6 Benzinga

Jan 4, 2022

09:01AM EST Citius Pharmaceuticals, Inc. to Present at Upcoming Virtual Conferences PR Newswire

Dec 15, 2021

04:34PM EST Citius Pharmaceuticals FY21 EPS $(0.23) Benzinga

04:31PM EST Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2021 Financial Results PR Newswire

Dec 6, 2021

09:18AM EST Citius Completes Enrollment In Phase 3 Study Of Cancer Immunotherapy I/ONTAK For Treatment Of Cutaneous T-Cell Lymphoma RTTNews

09:17AM EST Citius Pharmaceuticals Completes Enrollment In Pivotal Phase 3 Study Of Its Cancer Immunotherapy I/ONTAK For Treatment Of Cutaneous T-Cell Lymphoma Benzinga

09:15AM EST Citius Pharmaceuticals Completes Enrollment in the Pivotal Phase 3 Study of its PR Newswire

Nov 30, 2021

04:51PM EST Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021 Benzinga

04:49PM EST Maxim Group Initiates Coverage On Citius Pharmaceuticals with Buy Rating, Announces Price Target of $4 Benzinga

Nov 5, 2021

09:17AM EDT Citius Pharmaceuticals Appoints Kelly Creighton As EVP Of Chemistry, Manufacturing And Controls RTTNews

09:15AM EDT Creighton, PhD as Executive Vice President of Chemistry, Manufacturing and Controls PR Newswire

Oct 25, 2021

09:29AM EDT Citius Pharma To Host Key Opinion Leader Webinar 'webinar on the compelling need to salvage central venous catheters in patients with central line associated blood stream infections' Thursday, Nov. 11 At 11:30 a.m. ET Benzinga

09:16AM EDT Citius Pharmaceuticals to Host Key Opinion Leader Webcast on the Compelling PR Newswire

Oct 13, 2021

11:39AM EDT Citius Pharmaceuticals to Host Investor Webcast to Discuss the Acquisition of PR Newswire

Oct 6, 2021

10:42AM EDT Benzinga Announces The 8 'Rising Star' Companies Being Featured On Its Next 'All Access' Show Benzinga

10:41AM EDT Citius Pharmaceuticals to Present at Upcoming October Investor Conferences PR Newswire

Oct 1, 2021

08:31AM EDT Temple University Renames College of Liberal Arts Main Campus Building in Honor PR Newswire

Sep 14, 2021

10:07AM EDT Citius Pharmaceuticals to Join Benzinga All Access Show on Friday, September PR Newswire

Sep 10, 2021

07:35PM EDT Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential Benzinga

Sep 8, 2021

09:15AM EDT Citius Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global PR Newswire

Sep 7, 2021

08:14AM EDT Citius Pharmaceuticals, Inc. (CTXR) has entered into a definitive agreement with Dr. Reddy's Laboratories SA (RDY) to acquire its exclusive license of E7777, a late-stage oncology immunotherapy for the treatment of cutaneous T-cell lymphoma. Citius will acquire Dr. Reddy's exclusive license of E7777 from Eisai Co. and other related assets owned by Dr. Reddy's. RTTNews

07:33AM EDT Citius Buys Dr. Reddy's License For Late-Phase 3 Oncology Immunotherapy For Treatment Of CTCL, Other Cancer Indications RTTNews

07:31AM EDT Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications PR Newswire

Aug 12, 2021

05:16PM EDT Citius Pharmaceuticals Q3 EPS $(0.05) Up From $(0.11) YoY Benzinga

04:31PM EDT Citius Pharmaceuticals, Inc. Reports Third Fiscal Quarter 2021 Financial PR Newswire

Aug 10, 2021

02:42PM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Aug 4, 2021

10:34AM EDT Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs Benzinga

Jul 23, 2021

04:35PM EDT Citius Pharma Filing Shows Registration For ~1.6M Share Common Stock Upon Exercise Of Warrants Offering Benzinga

Jul 7, 2021

09:35AM EDT UPDATE: Citius Pharmaceuticals Says Financial Flexibility Expanded With $127.6M In Financing Activities During First Half Of 2021 Benzinga

09:33AM EDT Citius Pharmaceuticals Says Mino-Lok NDA Submission Planned For 2022 Following Anticipated Completion Of Phase 3 Trial By End Of 2021 Or Early 2022 Benzinga

09:20AM EDT Citius Pharmaceuticals, Inc. Provides First Half 2021 Business Update, PR Newswire

Jul 1, 2021

02:34PM EDT Mid-Afternoon Market Update: Dow Gains 100 Points; NovoCure Shares Plunge Benzinga

12:06PM EDT Mid-Day Market Update: Crude Oil Rises Over 2%; Aligos Therapeutics Shares Slide Benzinga

10:36AM EDT Mid-Morning Market Update: Markets Open Higher; Walgreens Posts Q3 Profit Benzinga

09:03AM EDT Data Monitoring Committee to Continue the Mino-Lok(r) Phase 3 Trial as Planned PR Newswire

09:03AM EDT Citius Pharmaceuticals, Inc. Announces Recommendation By Independent Data Monitoring Committee To Continue Mino-Lok Phase 3 Trial As Planned Benzinga

09:03AM EDT Citius Announces Positive Recommendation By Independent Data Monitoring Committee To Continue Mino-Lok Phase 3 Trial RTTNews

Jun 24, 2021

08:12AM EDT The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO Benzinga

Jun 23, 2021

09:25AM EDT Citius Shows a Promising Future as Share Prices Keep Going up Benzinga

07:35AM EDT The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway Benzinga

Jun 22, 2021

08:12AM EDT The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal Benzinga

Jun 18, 2021

07:46AM EDT The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs Benzinga

Jun 17, 2021

08:33AM EDT The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme Benzinga

Jun 16, 2021

05:56PM EDT Top 3 Penny Stocks to Buy Right Now for Your 2021 Summer Watchlist Benzinga

08:20AM EDT The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO Benzinga

05:02AM EDT 44 Biggest Movers From Yesterday Benzinga

Jun 15, 2021

09:20AM EDT Citius Pharmaceuticals Expands Scientific Advisory Board with Addition of Dr. PR Newswire

Jun 8, 2021

02:11PM EDT Citius Pharma Plans Interim Analysis for Mino-Lok By End of June Benzinga

09:05AM EDT Citius Pharmaceuticals Says DMC To Hold Meeting To Review Mino-Lok Phase 3 Trial Benzinga

09:02AM EDT Citius Pharmaceuticals Achieves Next Interim Analysis Milestone in its PR Newswire

Jun 7, 2021

09:09AM EDT Citius Pharmaceuticals To Be Added To Russell 2000 Index On June 28 Benzinga

09:01AM EDT Citius Pharmaceuticals to be Added to Russell 2000(r) Index PR Newswire

May 25, 2021

02:53PM EDT Citius Pharmaceuticals Selected to Receive Best Poster Award at the PR Newswire

May 18, 2021

09:39AM EDT Citius Pharmaceuticals To Feature Updated Positive Interim Results Of I-MSC Study During Poster Presentation RTTNews

09:36AM EDT Citius Pharmaceuticals To Feature Updated Positive Interim Results Of i-MSC Study During Poster Presentation At International Society For Cell And Gene Therapy Benzinga

09:30AM EDT Study During Poster Presentation at International Society for Cell and Gene Therapy PR Newswire

May 17, 2021

12:30PM EDT Citius Pharmaceuticals, Inc. Announces Appointment of Ilanit Allen as Vice PR Newswire

May 13, 2021

02:14PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Says Not Planning On Offerings In Near Future Benzinga

02:12PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Highlights Co's i-MSC's Advantages Benzinga

02:08PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Says Patents Are Covered Through 2035 Benzinga

02:06PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Highlights Mino-Lok Phase 3 Pivotal Trial Design Benzinga

02:05PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Highlights Mino-Lok's Phase 2b Results Benzinga

02:03PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Highlights Co's Mino-Lok's Lack Of Competitors Benzinga

02:01PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Says Will Start Phase 2b Trial This Year For HALO-LIDO Benzinga

01:59PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Highlights Management Of Co Benzinga

01:58PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Says There Are No FDA Approved Products For Hemorrhoids Benzinga

01:57PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Highlights CRBSI Worldwide Market Is ~$1.8B; TE Infection Market ~$400M, RX Hemorrhoid Market ~$2B In U.S. Benzinga

01:56PM EDT From BZ Global Small-Cap Event: Citius Pharmaceuticals President, CEO Myron Holubiak Says Co Currently Has 4 Active Programs Benzinga

08:34AM EDT Citius Pharma S-3 Shows Registration For 25.04M Share Common Stock Offering Via Selling Shareholders Benzinga

07:33AM EDT Citius Pharmaceuticals Q2 EPS $(0.04) Up From $(0.13) YoY Benzinga

07:31AM EDT Citius Pharmaceuticals, Inc. Reports Second Fiscal Quarter 2021 Financial PR Newswire

May 11, 2021

04:30PM EDT Citius Pharmaceuticals to Participate in Fireside Chat at the Gabelli Funds PR Newswire

May 4, 2021

09:15AM EDT Treatment Update at Benzinga Global Small Cap Conference on Thursday, May 13 PR Newswire

Apr 29, 2021

09:39AM EDT Citius Reports Strong Clinical Community Engagement During Mino-Lok Phase 3 Trial-Related Webinar RTTNews

09:38AM EDT Citius Pharma Highlights 'Strong' Clinical Community Engagement During Its Mino-Lok Phase 3 Trial-Related Webinar Benzinga

09:37AM EDT Citius Pharmaceuticals Reports Strong Clinical Community Engagement During PR Newswire

Apr 22, 2021

04:30PM EDT Citius Pharmaceuticals CEO Myron Holubiak Featured in Benzinga Interview PR Newswire

Apr 19, 2021

08:53AM EDT Citius Thrives in 2021 with Critical Care Solutions for ARDS Associated with COVID-19 Benzinga

Apr 8, 2021

05:25PM EDT Exclusive: Citius Pharmaceuticals Exec Chairman On Product Pipeline, Potential $1B TAM Benzinga

01:27PM EDT EXCLUSIVE: Citius Pharmaceuticals Executive Chairman, Leonard Mazur Says Co. Has Raised Substantial Sum Of Money, Says Nothing On Horizon Would Indicate Co. Needs To Do A Raise Benzinga

01:24PM EDT EXCLUSIVE: Citius Pharmaceuticals Executive Chairman, Leonard Mazur Says Mino-Lok Phase 3 DMC Meeting Being Held In Q2 Of This Year, Will Evaluate Efficacy Readout Of Data Benzinga

01:17PM EDT EXCLUSIVE: Citius Pharmaceuticals Executive Chairman, Leonard Mazur, On analyst Coverage, Says As Co. Generates Data, Could Have More Coverage In Place Benzinga

01:16PM EDT EXCLUSIVE: Citius Pharmaceuticals Executive Chairman, Leonard Mazur Says Believes Market Size For Catheters Is $750M-$1B In Value In US; Says Outside US, Problem Is worse Benzinga

09:39AM EDT EXCLUSIVE: Citius Pharmaceuticals Executive Chairman, Leonard Mazur To Appear On Benzinga's 'Power Hour' Show At 1 p.m. EDT Benzinga

Mar 25, 2021

03:23PM EDT From BZ Biotech Conference: Citius Pharmaceuticals Executive Chairman Leonard Mazur Says DMC Meeting For Mino-Lok Coming Up In Q2; Hoping To Have Drug In The Market Some Time In 2022 Benzinga

03:19PM EDT From BZ Biotech Conference: Citius Pharmaceuticals Executive Chairman Leonard Mazur Says Co Has Diversified Mutli-Billion Dollar Opportunities; Multiple Near-Term Milestones Benzinga

03:12PM EDT From BZ Biotech Conference: Citius Pharmaceuticals Executive Chairman Leonard Mazur Says Lead Product Mino-Lok Is A Major Step Forward In Addressing A Serious Unmet Medical Need; Says 'There Is No Product Really That Is Competitive To Us' Benzinga

Mar 23, 2021

09:04AM EDT Citius Pharmaceuticals To Highlight Its Phase 3 Clinical Trial Product Mino-Lok At Benzinga Biotech Small Cap Conference On March 25 Benzinga

09:03AM EDT Citius Pharmaceuticals to Highlight its Phase 3 Clinical Trial Product PR Newswire

Mar 4, 2021

10:39AM EST Citius Pharmaceuticals to Feature Product Candidates Including Stem-Cell Therapy for COVID-19-Related Acute Respiratory Conditions at H.C. Wainwright Global Life Sciences Conference March 9-10 Benzinga

10:39AM EST Therapy for COVID-19-Related Acute Respiratory Conditions at H.C. Wainwright Global Life Sciences Conference March 9-10 PR Newswire

Feb 23, 2021

07:25AM EST The Daily Biotech Pulse: Aridis To Study Antibody Cocktail For Coronavirus Variants, Revance & Protalix Data Readouts Benzinga

Feb 22, 2021

10:13AM EST Mid-Morning Market Update: Markets Open Lower; DISH Network Profit Beats Views Benzinga

Feb 19, 2021

04:48PM EST Citius Pharmaceuticals Announces Closing of $76.5 Million Registered Direct PR Newswire

Feb 17, 2021

07:27AM EST The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal Benzinga

12:36AM EST Citius Pharmaceuticals Announces $76.5 Mln Registered Direct Offering Priced At-the-Market Under Nasdaq Rules RTTNews

12:29AM EST Citius Pharmaceuticals Announces $76.5 Million Registered Direct Offering PR Newswire

Feb 16, 2021

09:39AM EST Citius Pharma Reports Shareholder Letter, Highlights Expected 2021 Milestones Benzinga

09:16AM EST Citius Pharmaceuticals Issues Shareholder Letter with Corporate Update on PR Newswire

Feb 8, 2021

08:35AM EST Small and Microcap Company Investor Presentations Now Available for On-Demand PR Newswire

Feb 4, 2021

10:16AM EST Citius Pharmaceuticals Is Addressing Several Unmet Needs In The Medical Field Benzinga

07:22AM EST The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOs Benzinga

Feb 2, 2021

08:04AM EST Citius Pharma Reports Will Present Update On Mino-Lok, Other Therapies At Virtual Investor Conferences Small and Microcap Showcase on Thursday, Feb. 4, 2021 Benzinga

08:03AM EST Citius Pharmaceuticals to Present Update on Mino-Lok and Other Therapies at the PR Newswire

Jan 29, 2021

04:15PM EST Citius Pharmaceuticals Files Prospectus Relating To Sale Of 15.5M Shares Of Common Stock Offering By Selling Stockholders Benzinga

Jan 28, 2021

08:35AM EST Live Investor Conference & Webinar: Small and Microcap Company Showcase on PR Newswire

Jan 27, 2021

01:01PM EST Citius Pharmaceuticals Announces Closing of $20.0 Million Private Placement PR Newswire

Jan 25, 2021

07:02AM EST Citius Pharma Announces $20M Offering at $1.284/Share Benzinga

07:00AM EST Citius Pharmaceuticals Announces $20.0 Million Private Placement Priced PR Newswire

Jan 6, 2021

09:03AM EST Citius Pharmaceuticals to Present Update on Proprietary Product Candidates at PR Newswire

Dec 15, 2020

09:40AM EST Citius Holds Webinar Series on Conducting Mino-Lok Phase 3 Trial During COVID-19 PR Newswire

Dec 9, 2020

09:44AM EST Citius : FDA Grants Written Response Only Meeting Regarding Guidance And Direction On The Mino-Wrap Development Plan RTTNews

09:40AM EST Citius Pharmaceuticals Receives FDA Response and Guidance to Pre-IND PR Newswire

09:40AM EST Citius Pharma Reports Receives FDA Response, Guidance To Pre-Investigational New Drug Consultation Submission For Mino-Wrap Benzinga

08:51AM EST From BZ Small Cap Event: Citius Chair Highlighting Its Licensed NoveCite For Severe Acute Respiratory Syndrome Coronavirus 2 Benzinga

08:50AM EST From BZ Small Cap Event: Citius Pharma Chair Believes Cost Of Mino-Lok Will Be Between $1,400-$2,000 Benzinga

08:25AM EST From BZ Small Cap Event: Citius Pharma Chair Sees Interim Safety/Efficacy Analysis From Mino-Lok In Q1'21 Benzinga

08:24AM EST From BZ Small Cap Event: Citius Pharma Chair Sees Phase 2b Trial For Halo-Lido Initiated Q2'21 Benzinga

08:24AM EST From BZ Small Cap Event: Citius Pharma Chair Highlighting Pipeline, Says Mino-Lok Is Lead Candidate Benzinga

08:23AM EST From BZ Small Cap Event: Citius Pharma Chair Says 'You're Not Gonna Find A Management Team' Who Has More Confidence In What We're Doing Benzinga

Dec 8, 2020

04:42PM EST From BZ Small Cap Event: Citius Chair Says Mgmt. Has Close To A Third Of The Shares Of The Co., Believes Is Currently Undervalued Benzinga

11:45AM EST From BZ Small Cap Event: Citius Chair Highlighting Its Licensed NoveCite For Severe Acute Respiratory Syndrome Coronavirus 2 Benzinga

11:43AM EST From BZ Small Cap Event: Citius Pharma Chair Believes Cost Of Mino-Lok Will Be Between $1,400-$2,000 Benzinga

11:43AM EST From BZ Small Cap Event: Citius Pharma Chair Sees Interim Safety/Efficacy Analysis From Mino-Lok In Q1'21 Benzinga

11:39AM EST From BZ Small Cap Event: Citius Pharma Chair Sees Phase 2b Trial For Halo-Lido Initiated Q2'21 Benzinga

11:38AM EST From BZ Small Cap Event: Citius Pharma Chair Highlighting Pipeline, Says Mino-Lok Is Lead Candidate Benzinga

11:36AM EST From BZ Small Cap Event: Citius Pharma Chair Says 'You're Not Gonna Find A Management Team' Who Has More Confidence In What We're Doing Benzinga

11:34AM EST Citius Pharma's Chair Leonard Mazur Beginning Presentation At Benzinga's Small Cap Conference Benzinga

11:34AM EST Citius Pharma Chair, Leonard Mazur, Beginning Presentation At Benzinga's Small Cap Conference, Giving Co. Overview Benzinga

11:32AM EST Citius Pharma Presentation At Benzinga's Small Cap Event About To Begin Benzinga

09:17AM EST Citius Pharma Reports Its NoveCite Subsidiary Offered Data From Study Of Induced Mesenchymal Stem Cell Therapy In In Vivo Model Of Acute Respiratory Distress Syndrome Benzinga

09:16AM EST Induced Mesenchymal Stem Cell ("i-MSC") Therapy in an in vivo Model of Acute Respiratory Distress Syndrome ("ARDS") PR Newswire

Dec 7, 2020

05:22PM EST Schedule Of NYSE-, Nasdaq-Listed Publicly-Traded Companies Presenting At Benzinga's Small Cap Conference Dec. 8-9 Benzinga

Dec 3, 2020

03:30PM EST Citius Pharmaceuticals to Present Corporate Update at Benzinga Global Small Cap PR Newswire

Nov 30, 2020

09:16AM EST Citius Announces Results Of Study That Mino-Lok Eradicates S. Aureus Biofilm More Effectively, Expeditiously Than Components Benzinga

09:15AM EST Citius Announces Results of Study that Mino-Lok Eradicates S. aureus Biofilm PR Newswire

Nov 10, 2020

09:31AM EST Citius Pharmaceuticals to Present at Virtual Fall Investor Summit PR Newswire

Nov 9, 2020

09:30AM EST Citius Pharmaceuticals to Present at H.C. Wainwright 6th Annual Israel PR Newswire

Oct 27, 2020

09:09AM EDT Citius Pharma Sends Letter To Shareholders Benzinga

09:03AM EDT Citius Pharmaceuticals Issues October 2020 Letter to Shareholders PR Newswire

Oct 26, 2020

08:41AM EDT Citius Pharmaceutics Expects Mini-Lok Phase 3 Trial Will Continued As Planned Until It Is Fully Enrolled, Expect To Be In First Half Of 2021 Benzinga

08:40AM EDT Citius Pharma 8-K Shows Letter To Shareholders Benzinga

Oct 13, 2020

07:38AM EDT Novellus Therapeutics Licenses Induced MSCs To NoveCite For COVID-19 Related ARDS, Other Acute Respiratory Conditions RTTNews

07:33AM EDT UPDATE: Novellus Is 25% Equity Holder In Citius Pharma's NoveCite; Novellus To Receive $5M Upfront Payment, Eligible To Receive Up To $51M In Development Milestone Payments Benzinga

07:32AM EDT Novellus Therapeutics Reports It Has Licensed Its Induced Mesenchymal Stem Cells On Global Basis To Newly-Formed Subsidairy Of Citius Pharma, NoveCite; NoveCite To Develop, Commercialize For Acute Respiratory Conditions Benzinga

07:31AM EDT (iMSCs) to NoveCite for COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) and Other Acute Respiratory Conditions PR Newswire

Oct 7, 2020

07:07AM EDT Citius Pharma Signs Worldwide Licensing Agreement With Novellus Therapeutics For Unique IMSC-Therapy RTTNews

07:01AM EDT Citius Pharmaceuticals Signs Exclusive Worldwide Licensing Agreement With Novellus Therapeutics For Unique iMSC-Therapy For Acute Inflammatory Respiratory Conditions Including COVID-19 Related Acute Respiratory Distress Syndrome Benzinga

07:01AM EDT Novellus Therapeutics for Unique iMSC-Therapy for Acute Inflammatory Respiratory Conditions including COVID-19 Related Acute Respiratory Distress Syndrome (ARDS) PR Newswire

Sep 30, 2020

09:46AM EDT Citius's Mino-Lok trial sites resupplied with registration batch product PR Newswire

Sep 29, 2020

10:21AM EDT Citius Reports Positive Results From Recent Data Monitoring Committee Meeting For Mino-Lok Phase 3 Trial RTTNews

10:19AM EDT Citius Pharmaceuticals Reports Positive Results From Recent Data Monitoring Committee Meeting For Mino-Lok Phase 3 Trial Benzinga

10:18AM EDT Citius Pharmaceuticals Reports Positive Results from Recent Data Monitoring PR Newswire

Sep 22, 2020

08:21AM EDT Citius Pharmaceuticals Achieves Number Of Significant Milestones Over Past Several Weeks For Mino-Lok RTTNews

08:16AM EDT Citius Pharmaceuticals Highlights Chemical Manufacturing And Control Milestones For Mino-Lok Benzinga

08:15AM EDT Citius Pharmaceuticals Achieves Chemical Manufacturing and Control Milestones PR Newswire

Sep 15, 2020

10:21AM EDT Citius Files Addendum To Mino-Lok Phase 3 Trial Record Keeping Protocol To Advance Trials With COVID-19 Compliance RTTNews

10:18AM EDT Citius Files Addendum To Mino-Lok Phase 3 Trial Record Keeping Protocol To Advance Trials With Coronavirus Compliance Benzinga

10:17AM EDT Citius Files Addendum to Mino-Lok Phase 3 Trial Record Keeping Protocol to PR Newswire

Sep 8, 2020

10:01AM EDT Citius Pharmaceuticals to Present at H.C. Wainwright Virtual 22nd Annual Global PR Newswire

Aug 27, 2020

09:01AM EDT Citius Pharmaceuticals to Present at the LD 500 Virtual Conference PR Newswire

Aug 26, 2020

10:02AM EDT Citius Pharmaceuticals Announces Improved Design, Expansion Of Intellectual Property For Mino-Wrap Benzinga

10:01AM EDT Citius Pharmaceuticals Announces Improved Design and Expansion of Intellectual PR Newswire

Aug 13, 2020

09:47AM EDT Citius Pharmaceuticals Shares Spike Higher; Co. Announces To Present At MoneyShow Las Vegas Virtual Expo Benzinga

09:45AM EDT Citius Pharmaceuticals to Present at the MoneyShow Las Vegas Virtual Expo PR Newswire

Aug 10, 2020

03:19PM EDT Citius Pharmaceuticals Announces Closing of $9.6 Million Bought Deal Offering PR Newswire

Aug 5, 2020

09:00PM EDT Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to PR Newswire

05:53PM EDT Citius Pharma Prices ~5.7M Share Common Stock Offering At $1.05/Share Benzinga

05:33PM EDT Citius Pharmaceuticals Announces $6.0 Million Bought Deal Offering PR Newswire

Aug 4, 2020

08:20AM EDT Citius Says Submits Mino-Wrap Briefing Package To FDA For Pre-IND Consult RTTNews

08:19AM EDT Citius Submits Mino-Wrap Briefing Package To FDA For Pre-IND Consult Benzinga

Jul 22, 2020

10:35AM EDT Citius Forms Board For Development Of Proprietary Treatment For Acute Respiratory Disease Associated With COVID-19 RTTNews

10:32AM EDT Citius Pharmaceuticals Forms Scientific Advisory Board For Planned Development Of Proprietary Treatment For Acute Respiratory Disease Associated With Coronavirus Benzinga

10:31AM EDT Development of its Proprietary Treatment for Acute Respiratory Disease Associated with COVID-19 PR Newswire

Jul 20, 2020

02:00PM EDT Citius Pharmaceuticals to Present at the MoneyShow Accredited Investor Virtual PR Newswire

Jul 14, 2020

08:54AM EDT Myron Czuczman Joins Citius As Chief Medical Officer And EVP RTTNews

08:47AM EDT Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical PR Newswire

Jul 13, 2020

08:16AM EDT Citius Pharma Regains Compliance With Nasdaq Listing Requirements RTTNews

08:16AM EDT Citius Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements Benzinga